Abstract
Pianezza et al. (1998) reported an association between the CYP2A6 gene, which codes for the enzyme that metabolizes nicotine to cotinine, and cigarette smoking behavior. We attempted to replicate their findings by analyzing the CYP2A6 gene in a population of 385 individuals using the same two-step PCR assay described by Pianezza et al. but found no association between genotype and either smoking status or cigarette consumption. We then developed a single-step PCR method that is specific for the CYP2A6 locus and eliminates a high rate of false-positive mutations detected by the two-step assay. Although this assay gave a much lower frequency of mutant alleles, there was again no association of CYP2A6 genotype with smoking behavior.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Benjamin, J., Li, L., Patterson, C., Greenberg, B. D., Murphy, D. L., and Hamer, D. H. (1996). Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nature Genet. 12:81-84.
Carmelli, D., Swan, G. E., Robinette, D., and Fabsitz, R. (1992). Genetic influence on smoking: a study of male twins. N. Engl. J. Med. 327:829-833.
Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences, Erlbaum, Hillsdale, NJ.
Fernandez-Salguero, P., Hoffman, S. M., Cholerton, S., Mohrenweiser, H., Raunio, H., Rautio, A., Pelkonen, O., Huang, J. D., Evans, W. E., Idle, J. R., et al. (1995). A genetic polymorphism in coumarin 7-hydroxylation: Sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. Am. J. Hum. Genet. 57:651-660.
Gullsten, H., Agundez, J. A., Benitez, J., Laara, E., Ladero, J. M., Diaz-Rubio, M., Fernandez-Salguero, P., Gonzalez, F., Rautio, A., Pelkonen, O., and Raunio, H. (1997). CYP2A6 gene polymorphism and risk of liver cancer and cirrhosis. Pharmacogenetics 7:247-250.
Hadidi, H., Zahlsen, K., Idle, J. R., and Cholerton, S. (1997). A single amino acid substitution (Leul60His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin. Food Chem. Toxicol. 35:903-907.
Hamer, D. H., and Copeland, P. (1994). The Science of Desire, Simon and Schuster, New York.
Heath, A. C., and Madden, P. G. (1995). Genetic influences on smoking behavior. In Turner, J. R., Cardon, L. R., and Hewitt, J. K. (eds.), Behavior Genetic Approaches in Behavioral Medicine, Plenum, New York, pp. 37-48.
Heath, A. C., and Martin, N. (1993). Genetic models for the natural history of smoking: Evidence for a genetic influence on smoking persistence. Addict. Behav. 18:19-34.
Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., and Fagerstrom, K. O. (1991). The Fagerstrom Test for Nicotine Dependence: A revision of the Fgerstrom Tolerance Questionnaire. Br. J. Addict. 86:1119-1127.
Lesch, K. P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Muller, C. R., Hamer, D. H., and Murphy, D. L. (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531.
London, S. J., Idle, J. R., Daly, A. K., and Coetzee, G. A. (1999). Genetic variation of CYP2A6, smoking, and risk of cancer. Lancet 353:898-899.
Miles, J. S., McLaren, A. W., Forrester, L. M., Glancey, M. J., Lang, M. A., and Wolf, C. R. (1990). Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity. Biochem. J. 267:365-371.
Nunoya, K., Yokoi, T., Kimura, K., Inoue, K., Kodama, T., Funayama, M., Nagashima, K., Funae, Y., Green, C., Kinoshita, M., and Kamataki, T. (1998). A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin. Pharmacogenetics 8:239-249.
Oscarson, M., Gullsten, H., Rautio, A., Bernal, M. L., Sinues, B., Dahl, M. L., Stengard, J. H., Pelkonen, O., Raunio, H., and Ingelman-Sundberg, M. (1998). Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase. FEBS Lett. 438:201-205.
Pianezza, M. L., Sellers, E. M., and Tyndale, R. F. (1998). Nicotine metabolism defect reduces smoking. Nature 25:750-751.
Pomerleau, C. S., Carton, S. M., Lutzke, M. L., Flessland, K. A., and Pomerleau, O. F. (1994). Reliability of the Fagerstrom Tolerance Questionnaire and the Fagerstrom Test for Nicotine Dependence. Addict. Behav. 19:33-39.
Sabol, S. Z., Nelson, M. L., Fisher, C., Gunzerath, L., Brody, C. L., Hu, S., Sirota, L. A., Marcus, S. E., Greenberg, B. D., Lucas, F. R., IV, Benjamin, J., Murphy, D. L., and Hamer, D. H. (1999). A genetic association for cigarette smoking behavior. Health Psychol. 18:7-13.
Yamano, S., Tatsuno, J., and Gonzalez, F. J. (1990). The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in liver microsomes. Biochemistry 29:1322-1329.
Yokoi, T., and Kamataki, T. (1998). Genetic polymorphism of drug metabolizing enzymes: New mutations in CYPD6 and CYP2A6 genes in Japanese. Pharm. Res. 15:517-524.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sabol, S.Z., Hamer, D.H. An Improved Assay Shows No Association Between the CYP2A6 Gene and Cigarette Smoking Behavior. Behav Genet 29, 257–261 (1999). https://doi.org/10.1023/A:1021642323602
Issue Date:
DOI: https://doi.org/10.1023/A:1021642323602